Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Targeted Therapy on Cancer-Related Cognitive Impairment

NCT07638007 is registered in ClinicalTrials.gov with University of Rochester NCORP Research Base as lead sponsor.

NCT NCT07638007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07638007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
Lead sponsor
University of Rochester NCORP Research Base
Phase
Observational
Overall status
Recruiting
Start date
November 21, 2025
Completion date
February 28, 2029
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia (cll), chronic myeloid leukemia, bcr-abl1 positive, disease/condition name cancer-related cognitive dysfunction